Literature DB >> 32504295

GMP-Compliant Human Schwann Cell Manufacturing for Clinical Application.

Babak Arjmand1,2, Parisa Goodarzi3, Sepideh Alavi-Moghadam4, Moloud Payab5, Hamid Reza Aghayan6, Fereshteh Mohamadi-Jahani3, Akram Tayanloo-Beik6, Neda Mehrdad7, Bagher Larijani8.   

Abstract

Schwann cells as glial cells in the peripheral nervous system can participate in neurons protection and forming myelin. Additionally, they are important for nerve pulse conduction supporting along axons. On the other hand, it was demonstrated that they are promising cells for the treatment of demyelinating disorders and also central nervous system damages. Herein, for therapeutic application, Schwann cells should be manufactured based on good manufacturing practice standards to achieve safe and effective clinical products. In this respect, the current chapter tries to introduce a standard protocol for manufacturing of human GMP-compliant Schwann cells for clinical application.

Entities:  

Keywords:  Clinical application; GMP; Peripheral nervous system; Quality assurance; Schwann cells

Year:  2021        PMID: 32504295     DOI: 10.1007/7651_2020_283

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  Human autologous serum as a substitute for fetal bovine serum in human Schwann cell culture.

Authors:  Parisa Goodarzi; Babak Arjmand; Seyed Hassan Emami-Razavi; Masoud Soleimani; Abbas Khodadadi; Fereshteh Mohamadi-Jahani; Hamid Reza Aghayan
Journal:  Acta Med Iran       Date:  2014
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.